Position in VNRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$162,200
+$55,340 QoQ
Shares Held
40,550
+97.3% QoQ
Ownership
0.487%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 31 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VNRX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $248,574,257 across 33 Medical Devices names. VNRX ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
613,310 | $62,968,537 | |
| 2 | MDT |
Medtronic plc
|
696,767 | $60,374,860 | |
| 3 | SYK |
Stryker Corp
|
151,677 | $49,839,545 | |
| 4 | BSX |
Boston Scientific Corp
|
473,400 | $29,705,850 | |
| 5 | DXCM |
Dexcom Inc
|
128,775 | $8,087,070 | |
| 6 | EW |
Edwards Lifesciences Corp
|
83,953 | $6,722,956 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
85,908 | $6,114,931 | |
| 8 | GMED |
Globus Medical Inc
|
42,497 | $3,661,541 |
All Filings in VNRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,200 | 40,550 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $106,860 | 20,550 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $272,680 | 20,050 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||